JP2013518563A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013518563A5 JP2013518563A5 JP2012551129A JP2012551129A JP2013518563A5 JP 2013518563 A5 JP2013518563 A5 JP 2013518563A5 JP 2012551129 A JP2012551129 A JP 2012551129A JP 2012551129 A JP2012551129 A JP 2012551129A JP 2013518563 A5 JP2013518563 A5 JP 2013518563A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- protein
- fragment
- derivative
- treponema
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004169 proteins and genes Human genes 0.000 claims 22
- 108090000623 proteins and genes Proteins 0.000 claims 22
- 239000012634 fragment Substances 0.000 claims 15
- 238000000034 method Methods 0.000 claims 13
- 241000589886 Treponema Species 0.000 claims 11
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 6
- 125000003275 alpha amino acid group Chemical group 0.000 claims 6
- 230000028993 immune response Effects 0.000 claims 6
- 201000010099 disease Diseases 0.000 claims 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
- 230000006806 disease prevention Effects 0.000 claims 3
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 150000007523 nucleic acids Chemical class 0.000 claims 3
- 201000004624 Dermatitis Diseases 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 238000000926 separation method Methods 0.000 claims 2
- 239000007790 solid phase Substances 0.000 claims 2
- 241000589906 Treponema sp. Species 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 210000001124 body fluid Anatomy 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 230000009261 transgenic effect Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29896010P | 2010-01-28 | 2010-01-28 | |
| US61/298,960 | 2010-01-28 | ||
| US36098610P | 2010-07-02 | 2010-07-02 | |
| US61/360,986 | 2010-07-02 | ||
| PCT/SE2011/050090 WO2011093783A1 (en) | 2010-01-28 | 2011-01-28 | Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013518563A JP2013518563A (ja) | 2013-05-23 |
| JP2013518563A5 true JP2013518563A5 (enExample) | 2014-03-13 |
Family
ID=44319584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012551129A Pending JP2013518563A (ja) | 2010-01-28 | 2011-01-28 | ワクチンにおいて使用するための組換えタンパク質、前記タンパク質に対する抗体、ならびに該タンパク質を含む診断法および療法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8703432B2 (enExample) |
| EP (1) | EP2528939B1 (enExample) |
| JP (1) | JP2013518563A (enExample) |
| CN (1) | CN102918053A (enExample) |
| AU (1) | AU2011209988A1 (enExample) |
| BR (1) | BR112012018840A2 (enExample) |
| CA (1) | CA2825282A1 (enExample) |
| NZ (1) | NZ601980A (enExample) |
| RU (1) | RU2012137304A (enExample) |
| WO (1) | WO2011093783A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10010423B2 (en) | 2013-03-15 | 2018-07-03 | Avinash Kumar | Anatomical humeral fixation system and method |
| JP5740062B1 (ja) | 2013-07-03 | 2015-06-24 | 三菱化学フーズ株式会社 | 毛状疣贅病の予防および／または治療方法 |
| US10022458B2 (en) | 2015-03-05 | 2018-07-17 | Iowa State University Research Foundation, Inc. | Animal model protocol, diagnostic, therapeutic and vaccine against digital dermatitis |
| MX2020005104A (es) * | 2017-11-17 | 2020-12-10 | Hipra Scient S L U | Composiciones de vacuna para uso contra dermatitis digital en un mamifero. |
| KR102177180B1 (ko) * | 2020-05-13 | 2020-11-10 | 순천대학교 산학협력단 | 신규 트레포네마 파지데니스 균주 및 이의 분리 방법 |
| KR102177181B1 (ko) * | 2020-05-14 | 2020-11-10 | 순천대학교 산학협력단 | 트레포네마 파지데니스 균주의 배양 조성물 및 이의 용도 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0534526A1 (en) * | 1991-09-25 | 1993-03-31 | Duphar International Research B.V | Treponema hyodysenteriae vaccine |
| IL103530A0 (en) * | 1991-10-25 | 1993-03-15 | Duphar Int Res | Treponema hyodysenteriae vaccine |
| US6287575B1 (en) | 1997-10-03 | 2001-09-11 | The Regents Of The University Of California | Vaccine against papillomatous digital dermatitis (PDD) |
| US6096323A (en) * | 1997-10-03 | 2000-08-01 | The Regents Of The University Of California | Vaccine against papillomatous digital dermatitis (PDD) |
-
2011
- 2011-01-28 US US13/576,032 patent/US8703432B2/en not_active Expired - Fee Related
- 2011-01-28 NZ NZ601980A patent/NZ601980A/en not_active IP Right Cessation
- 2011-01-28 RU RU2012137304/10A patent/RU2012137304A/ru not_active Application Discontinuation
- 2011-01-28 CN CN2011800077474A patent/CN102918053A/zh active Pending
- 2011-01-28 AU AU2011209988A patent/AU2011209988A1/en not_active Abandoned
- 2011-01-28 WO PCT/SE2011/050090 patent/WO2011093783A1/en not_active Ceased
- 2011-01-28 BR BR112012018840A patent/BR112012018840A2/pt not_active IP Right Cessation
- 2011-01-28 CA CA2825282A patent/CA2825282A1/en not_active Abandoned
- 2011-01-28 JP JP2012551129A patent/JP2013518563A/ja active Pending
- 2011-01-28 EP EP11737369.6A patent/EP2528939B1/en not_active Not-in-force
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008031133A3 (en) | Borrelia antigens | |
| JP2013518563A5 (enExample) | ||
| JP2010516290A5 (enExample) | ||
| JP2012515551A5 (enExample) | ||
| JP2010524489A5 (enExample) | ||
| JP2013524814A5 (enExample) | ||
| JP2016524592A5 (enExample) | ||
| JP2010166916A5 (enExample) | ||
| RU2015147287A (ru) | Гуманизированные антитела против axl | |
| HRP20150799T1 (hr) | Sastavi i postupci za protutijela protiv komplementnog proteina c5 | |
| BR112012008946A2 (pt) | sequência polinucletídica isolada , molécula pollinucleotídica de rna, vetor ou plasmídeo , célula hospedeira , vírus a ser expresso , vacina , polipetídeo e composição de vacina | |
| Gong et al. | Single-walled carbon nanotubes as delivery vehicles enhance the immunoprotective effects of a recombinant vaccine against Aeromonas hydrophila | |
| WO2008135446A3 (en) | Klebsiella antigens | |
| JP2011517938A5 (enExample) | ||
| JP2017503792A (ja) | ＯｓｐＡの突然変異体断片、並びにそれに関する方法および使用 | |
| JP2010535015A5 (enExample) | ||
| WO2010092176A3 (en) | Nontypable haemophilus influenzae antigens | |
| MX2015008448A (es) | Anticuerpos anti-lamp1 y conjugados anticuerpo farmaco, y usos de estos. | |
| KR101323845B1 (ko) | 외막소포체를 유효성분으로 포함하는 항암용 약제학적 조성물 | |
| WO2016155605A1 (zh) | 肺炎链球菌蛋白抗原及其制备方法和应用 | |
| CN110642927A (zh) | 一种蛋白在制备预防化脓隐秘杆菌感染的药物中的应用 | |
| Smidt et al. | Comprehensive antigen screening identifies Moraxella catarrhalis proteins that induce protection in a mouse pulmonary clearance model | |
| JP2015529677A5 (enExample) | ||
| RU2012137304A (ru) | Рекомбинантные белки для применения в вакцине, антитела к указанным белкам и диагностические и терапевтические способы, включающие указанное | |
| MX2012004448A (es) | Clones infecciosos de torque teno virus. |